[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent… Opinion that approval is possible under the premise of Phase 3
Ministry of Food and Drug Safety’s Central Pharmaceutical Affairs Commission “Recommendation for use of celltrion antibody therapy for moderate and high-risk patients with mild symptoms”: Dong-A Science
“Celltrion corona treatment, recommended for use only in moderate and high risk groups other than mild”… Ministry of Food and Drug Safety Phase 2 Consultation Results (General)
Celltrion Corona 19 Antibody Treatment, 2nd Consultation Results from the Ministry of Food and Drug Safety to be released on the 27th
![[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent… Opinion that approval is possible under the premise of Phase 3](https://cdn.bizwnews.com/news/thumbnail/202101/22949_23258_476_v150.jpg "[비즈헬스] Celltrion’s corona 19 treatment’Rekironaju’ approval is imminent… Opinion that approval is possible under the premise of Phase 3")
![[금일 제약업계 주요기사]The first corona19 vaccine in Korea?… SK Bioscience, Covid-19 vaccine distribution](http://www.youthdaily.co.kr/data/photos/20210103/art_16113021873275_fc402c.jpg "[금일 제약업계 주요기사]The first corona19 vaccine in Korea?… SK Bioscience, Covid-19 vaccine distribution")
